These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30124155)

  • 1. Managing Clopidogrel Hypersensitivity without Interrupting Therapy: The Toronto Approach.
    Cheema AN
    Curr Vasc Pharmacol; 2019; 17(2):119-122. PubMed ID: 30124155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach.
    Vishnevsky A; Savage MP; Fischman DL
    Curr Vasc Pharmacol; 2019; 17(2):123-126. PubMed ID: 30058491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity.
    Ather A; Beavers CJ
    Curr Vasc Pharmacol; 2019; 17(2):127-132. PubMed ID: 30058492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol.
    Bulva J; Simon RA
    Curr Vasc Pharmacol; 2019; 17(2):113-118. PubMed ID: 30378498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel Hypersensitivity: Pathogenesis, Presentation and Diagnosis.
    Ford MK; Cohn JR
    Curr Vasc Pharmacol; 2019; 17(2):110-112. PubMed ID: 30381080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel Hypersensitivity: Overview of the Problem.
    Savage MP; Fischman DL
    Curr Vasc Pharmacol; 2019; 17(2):108-109. PubMed ID: 30124153
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
    Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
    EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
    Zanchin T; Temperli F; Karagiannis A; Zanchin C; Räsänen M; Koskinas KC; Stortecky S; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Billinger M; Heg D; Pilgrim T; Valgimigli M; Windecker S; Räber L
    Circ Cardiovasc Interv; 2018 May; 11(5):e006132. PubMed ID: 29748219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching between P2Y
    Capranzano P; Capodanno D
    Vascul Pharmacol; 2019 May; 116():4-7. PubMed ID: 30876967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
    Page NA; Schroeder WS
    Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study.
    Fanaroff AC; Kaltenbach LA; Peterson ED; Akhter MW; Effron MB; Henry TD; Wang TY
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
    Deharo P; Quilici J; Camoin-Jau L; Johnson TW; Bassez C; Bonnet G; Fernandez M; Ibrahim M; Suchon P; Verdier V; Fourcade L; Morange PE; Bonnet JL; Alessi MC; Cuisset T
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2560-2570. PubMed ID: 29268886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switch to Ticagrelor in critical limb ischemia antiplatelet study (STT-CLIPS).
    Clavijo LC; Dhillon A; Al-Asady N; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):319-323. PubMed ID: 29329963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry.
    Lupi A; Bona RD; Meliga E; Capodanno D; Schaffer A; Bongo AS; Gaudio G; Guasti L; Alexopoulos D; Valgimigli M; Porto I
    Thromb Haemost; 2018 May; 118(5):852-863. PubMed ID: 29618159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of clopidogrel hypersensitivity without drug interruption.
    Campbell KL; Cohn JR; Fischman DL; Walinsky P; Mallya R; Jaffrani W; Savage MP
    Am J Cardiol; 2011 Mar; 107(6):812-6. PubMed ID: 21247516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel drug interactions: a review of the evidence and clinical implications.
    Lee CH; Franchi F; Angiolillo DJ
    Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1079-1096. PubMed ID: 32835535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Comparison of Oral P2Y
    Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
    JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic reactions to clopidogrel and cross-reactivity to other agents.
    Lokhandwala J; Best PJ; Henry Y; Berger PB
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):52-7. PubMed ID: 20941557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis.
    Piccolo R; Feres F; Abizaid A; Gilard M; Morice MC; Hong MK; Kim HS; Colombo A; Bhatt DL; Palmerini T; Stone GW; Windecker S; Valgimigli M
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1621-1630. PubMed ID: 28838471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.